Clinical trials in China
53,102 studies list at least one site in China. 20,301 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 15,909
- Recruiting
- 14,978
- Status unknown
- 12,156
- Not yet recruiting
- 4,513
- Active, not recruiting
- 3,019
- Terminated
- 1,094
Phase
- Phase 2
- 11,641
- Phase 1
- 7,895
- Phase 3
- 6,460
- Phase 4
- 3,251
- Early Phase 1
- 1,128
Most studied here
Who runs them
Sun Yat-sen University (1,490) · Fudan University (1,113) · Peking Union Medical College Hospital (955) · Second Affiliated Hospital, School of Medicine, Zhejiang University (919) · Peking University Third Hospital (607) · Ruijin Hospital (545) · Jiangsu HengRui Medicine Co., Ltd. (501) · Shanghai Zhongshan Hospital (478)
Studies
Recruiting first, then most recently updated. Showing 50 of 53,102 — search for more.
- FAP-targeting PET/CT for Noninvasive Monitoring of Renal FibrosisEnrolling by invitationNCT06563765Not applicable
- A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerRecruitingNCT06319820Phase 3
- A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresEnrolling by invitationNCT05076617Phase 3
- JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRecruitingNCT04892173Phase 3
- XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS MutationEnrolling by invitationNCT06936527Phase 1/2
- A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantRecruitingNCT05623020Phase 3
- A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal HemoglobinuriaEnrolling by invitationNCT07657052Not applicable
- A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerRecruitingNCT06385080Phase 1/2
- Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor SurgeryEnrolling by invitationNCT07841613
- A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
- Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast CancerNot yet recruitingNCT07419880Phase 2
- A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)RecruitingNCT04811560Phase 1/2
- Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under SedationNot yet recruitingNCT07637721Not applicable
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyRecruitingNCT06750094Phase 3
- A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot yet recruitingNCT07663630Phase 1
- A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic MalignanciesRecruitingNCT06224855Phase 1
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityNot yet recruitingNCT07792954Phase 3
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 3
- Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in AdultsNot yet recruitingNCT07835152Phase 3
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.RecruitingNCT06758401Phase 3
- Safety and Efficacy of Carotid Artery Stenting Combined With Intermittent Hypoxia Intervention in Patients With Severe Internal Carotid Artery StenosisNot yet recruitingNCT07837011Not applicable
- A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRecruitingNCT06150157Phase 1
- Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China (CLIMB)Not yet recruitingNCT07842835
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRecruitingNCT06662786Phase 3
- ALT001 in Patients With Ischemic Stroke in the Sequelae StageNot yet recruitingNCT07841496Phase 2
- A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaRecruitingNCT05552222Phase 3
- CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07841002Phase 1
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruitingNCT06807424Phase 3
- A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple DosesNot yet recruitingNCT07841860Phase 1
- A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelRecruitingNCT05201781Phase 4
- Household Salt Substitution for Hypertension Prevention and Control: The HOME-Salt TrialNot yet recruitingNCT07840742Not applicable
- A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaRecruitingNCT06807268Phase 3
- Clinical Study Examining the Control of Plaque and GingivitisNot yet recruitingNCT07842978Phase 3
- A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerRecruitingNCT05379595Phase 1/2
- A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic StrokeNot yet recruitingNCT07842185Phase 2/3
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaRecruitingNCT06807281Phase 3
- CEST-PROTECT: Proximal Flow Control With a Balloon Guide Catheter Plus Distal Embolic Protection: a Randomised, Open-label Trial Evaluating Cerebral Protection TechniquesNot yet recruitingNCT07841132Not applicable
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)RecruitingNCT06103864Phase 3
- A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid TumorsNot yet recruitingNCT07841925Phase 1/2
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)RecruitingNCT05139017Phase 2/3
- A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty ArthritisNot yet recruitingNCT07842497Phase 2
- HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular CarcinomaRecruitingNCT06737913Phase 2
- Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceNot yet recruitingNCT07842887Phase 1
- Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT06801236Phase 1
- Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue SarcomaNot yet recruitingNCT07842276Phase 2
- A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02)RecruitingNCT06618664Phase 3
- Real-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart FailureNot yet recruitingNCT07841275
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruitingNCT06742723Phase 3
- A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short Stature Children With Small for Gestational Age (SGA)Not yet recruitingNCT07841678Phase 3
- Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT05327114Phase 2/3